131 related articles for article (PubMed ID: 4653961)
1. Effect of amantadine on the urinary excretion of some monoamines and metabolites in normal and Parkinsonian subjects.
Jones DG; Turnbull MJ; Lenman JA; Robertson MA
J Neurol Sci; 1972 Nov; 17(3):245-53. PubMed ID: 4653961
[No Abstract] [Full Text] [Related]
2. Proceedings: Effect of amantadine on the urinary excretion of some monoamines and metabolites in normal and parkinsonian subjects.
Jones DG; Lenman JA; Robertson MA; Turnbull MJ
Br J Pharmacol; 1972 Feb; 44(2):386P-387P. PubMed ID: 4668639
[No Abstract] [Full Text] [Related]
3. [Catecholamine excretion and treatment of parkinsonism with midantan].
Kandel' EI; Iadgarov IS
Zh Nevropatol Psikhiatr Im S S Korsakova; 1976 Sep; 76(9):1323-6. PubMed ID: 1015136
[No Abstract] [Full Text] [Related]
4. Responses of the urinary excretion of homovanillic acid and of 5-hydroxy-indol-acetic acid to treatment with L-dopa and amantadine.
Molnár G; Fodor A
Ther Hung; 1973; 21(1):35-40. PubMed ID: 4792890
[No Abstract] [Full Text] [Related]
5. [The effect of alpha-DOPA on the dynamics of urinary excretion of DOPA, catecholamines and their metabolites in healthy subjects and in patients with parkinsonism].
Matlina ESh; Kandel' EI; Vasil'ev VN; Iadgarov IS; Bol'shakova TD
Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(2):205-9. PubMed ID: 4743269
[No Abstract] [Full Text] [Related]
6. The biochemistry of catecholamines in relation to Parkinson's disease.
Hinterberger H
Aust N Z J Med; 1971 May; 1():Suppl 1:14-8. PubMed ID: 5292808
[No Abstract] [Full Text] [Related]
7. Urinary excretion of some monoamines and metabolites in Huntington's chorea.
McNamee B; Kelvin AS; Turnbull MJ
Scott Med J; 1971 May; 16(5):247-9. PubMed ID: 4253483
[No Abstract] [Full Text] [Related]
8. Urinary monoamine metabolite excretion in disorders of movement. Effects of amantadine and levodopa.
Lenman JA; Turnbull MJ; Reid A; Fleming AM
J Neurol Sci; 1977 Jun; 32(2):219-25. PubMed ID: 874521
[TBL] [Abstract][Full Text] [Related]
9. Excretion of L-dopa and its metabolites in urine of Parkinson's disease patients receiving L-dopa therapy.
Routh JI; Bannow RE; Fincham RW; Stoll JL
Clin Chem; 1971 Sep; 17(9):867-71. PubMed ID: 5571485
[No Abstract] [Full Text] [Related]
10. [Modifications of catecholamine metabolism under the effect of a decarboxylase inhibitor associated with L-dopa and desipramine in patients with depressive and parkinsonian syndromes].
Geissbuhler F; Bartholini G; Gaillard JM; Tissot R
Encephale; 1971; 60(3):189-209. PubMed ID: 5119348
[No Abstract] [Full Text] [Related]
11. Development of a screening test for L-dopa and its metabolites in urine.
Routh JI; Bannow RE
Clin Chem; 1971 Sep; 17(9):872-4. PubMed ID: 5571486
[No Abstract] [Full Text] [Related]
12. Urinary excretion of monoamines and metabolites in patients dependent on and withdrawn from barbiturates.
Turnbull MJ; Ballinger BR
Psychopharmacologia; 1973 May; 30(2):103-8. PubMed ID: 4711367
[No Abstract] [Full Text] [Related]
13. Urinary excretion of dopamine and homovanillic acid during L-dopa treatment of Parkinson's disease.
Streifler M; Vardi Y; Kesten M; Oberman Z; Herzberg M
Isr J Med Sci; 1972 May; 81(5):597-601. PubMed ID: 5042950
[No Abstract] [Full Text] [Related]
14. Catecholamine metabolism during oral administration of levodopa.
Hinterberger H; Andrews CJ
Arch Neurol; 1972 Mar; 26(3):245-52. PubMed ID: 5061285
[No Abstract] [Full Text] [Related]
15. Excretion of catecholamines and tryptophan derivatives in schizophrenia.
Mileikovskii YA
Neurosci Behav Physiol; 1979; 9(4):325-8. PubMed ID: 158714
[No Abstract] [Full Text] [Related]
16. Studies on the metabolism and excretion of L-3,4-dihydroxyphenylalanine (L-DOPA) in human beings by gas chromatography.
Imai K; Sugiura M; Kubo H; Tamura Z; Oya K
Chem Pharm Bull (Tokyo); 1972 Apr; 20(4):759-64. PubMed ID: 5045616
[No Abstract] [Full Text] [Related]
17. Treatment of parkinsonism by amantadine and levodopa.
Mawdsley C; Williams IR; Pullar IA; Davidson DL; Kinloch NE
Clin Pharmacol Ther; 1972; 13(4):575-83. PubMed ID: 4557584
[No Abstract] [Full Text] [Related]
18. Metabolism of L-dihydroxyphenylalanine by patients with Parkinson's disease.
Tyce GM; Muenter MD; Owen CA
Mayo Clin Proc; 1970 Sep; 45(9):645-56. PubMed ID: 5311767
[No Abstract] [Full Text] [Related]
19. The effect of methyldopa on the excretion of catecholamines in patients with extrapyramidal disorders.
Metzel A; Holldorf A; Umbach W
Confin Neurol; 1967; 29(2):78-80. PubMed ID: 5591949
[No Abstract] [Full Text] [Related]
20. Treatment of Parkinson's disease with amantadine and L-Dopa.
Rinne UK; Sonninen V; Siirtola T
Eur Neurol; 1972; 7(4):228-40. PubMed ID: 4556618
[No Abstract] [Full Text] [Related]
[Next] [New Search]
